F. Delorme
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Periodontics top 5%
- Oral microbiology and periodontitis research
Papers in
- Co-authors
- William Geerts (2 shared papers)Jacques R. Leclerc (2 shared papers)Louis Desjardins (2 shared papers)F Jobin (1 shared paper)F Laroche (1 shared paper)B. Norris (1 shared paper)W. Lofters (1 shared paper)Theodore A. Vandenberg (1 shared paper)
In The Last Decade
F. Delorme
16 papers receiving 456 citations
Peers
Comparison fields: 5 of 62
- Internal Medicine 200
- Periodontics 62
- Cardiology and Cardiovascular Medicine 152
- Oncology 168
- Dermatology 44
Countries citing papers authored by F. Delorme
This map shows the geographic impact of F. Delorme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Delorme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Delorme more than expected).
Fields of papers citing papers by F. Delorme
This network shows the impact of papers produced by F. Delorme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Delorme. The network helps show where F. Delorme may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Delorme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 178 | |
| 2 | 1996 | 137 | |
| 3 | 1989 | 47 | |
| 4 | Prevention of Venous Thromboembolism after Knee Arthroplasty | 1996 | 25 |
| 5 | Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. | 1997 | 24 |
| 6 | 1998 | 15 | |
| 7 | 1992 | 15 | |
| 8 | 1988 | 14 | |
| 9 | 1980 | 13 | |
| 10 | 1989 | 6 | |
| 11 | 1996 | 5 | |
| 12 | Daunorubicin-albumin copolymer targeting to leukemic cells in vitro and in vivo. | 1984 | 5 |
| 13 | 1997 | 5 | |
| 14 | 1997 | 4 | |
| 15 | Chemotherapy with daunorubicin-anti-CEA conjugates in human colon adenocarcinoma grafted in nude mice. | 1984 | 2 |
| 16 | [Dissecting aneurysm and rupture of the aorto secondary to giant-cell aortitis. Case report and review of the literature]. | 1970 | 2 |
About F. Delorme
F. Delorme is a scholar working on Oncology, Surgery, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 16 papers that have together received 497 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Oral microbiology and periodontitis research (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Neutropenia and Cancer Infections (2 papers), Infectious Aortic and Vascular Conditions (1 paper) and Oral and gingival health research (1 paper). The work is most often cited by research in Internal Medicine (200 citations), Periodontics (62 citations), Cardiology and Cardiovascular Medicine (152 citations), Oncology (168 citations) and Dermatology (44 citations). F. Delorme has collaborated with scholars based in Canada and India. Frequent co-authors include William Geerts, Jacques R. Leclerc, Louis Desjardins, F Jobin, F Laroche, B. Norris, W. Lofters, Theodore A. Vandenberg, Elizabeth A. Eisenhauer and A. Muldal. Their work appears in journals such as Journal of the American Society of Echocardiography, Journal of Clinical Oncology, Annals of Internal Medicine, Investigational New Drugs and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.